These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8905004)

  • 21. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
    Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI.
    Murphy KR; Dhand R; Trudo F; Uryniak T; Aggarwal A; Eckerwall G
    Respir Med; 2015 Feb; 109(2):170-9. PubMed ID: 25596138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
    Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
    Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma.
    Chuchalin AG; Manjra AI; Rozinova NN; Skopková O; Cioppa GD; Till D; Kaiser G; Fashola T; Kottakis J
    J Aerosol Med; 2005; 18(1):63-73. PubMed ID: 15741775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
    Corren J; Korenblat PE; Miller CJ; O'Brien CD; Mezzanotte WS
    Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI.
    Seberová E; Andersson A
    Respir Med; 2000 Jun; 94(6):607-11. PubMed ID: 10921767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.
    Steffensen I; Faurschou P; Riska H; Rostrup J; Wegener T
    Allergy; 1995 Aug; 50(8):657-63. PubMed ID: 7503401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizer.
    Nielsen KG; Skov M; Klug B; Ifversen M; Bisgaard H
    Eur Respir J; 1997 Sep; 10(9):2105-9. PubMed ID: 9311511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma.
    Berger WE; Bleecker ER; O'Dowd L; Miller CJ; Mezzanotte W
    Allergy Asthma Proc; 2010; 31(1):49-59. PubMed ID: 20167145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similar bronchodilation with formoterol delivered by aerolizer or turbuhaler.
    Lötvall J; Mellén A; Arvidsson P; Palmqvist M; Radielovic P; Kottakis J; Pfister P
    Can Respir J; 1999; 6(5):412-6. PubMed ID: 10572207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction.
    Löfdahl CG; Andersson L; Bondesson E; Carlsson LG; Friberg K; Hedner J; Hörnblad Y; Jemsby P; Källén A; Ullman A; Werner S; Svedmyr N
    Eur Respir J; 1997 Nov; 10(11):2474-8. PubMed ID: 9426081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency.
    Palmqvist M; Persson G; Lazer L; Rosenborg J; Larsson P; Lötvall J
    Eur Respir J; 1997 Nov; 10(11):2484-9. PubMed ID: 9426083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler.
    Ringdal N; Derom E; Wåhlin-Boll E; Pauwels R
    Respir Med; 1998 Aug; 92(8):1017-21. PubMed ID: 9893769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formoterol Turbuhaler as reliever medication in patients with acute asthma.
    Rubinfeld AR; Scicchitano R; Hunt A; Thompson PJ; Van Nooten A; Selroos O
    Eur Respir J; 2006 Apr; 27(4):735-41. PubMed ID: 16455838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients.
    Peters SP; Prenner BM; Mezzanotte WS; Martin P; O'Brien CD
    Allergy Asthma Proc; 2008; 29(5):499-516. PubMed ID: 18694544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
    Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
    Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling.
    Eliraz A; Ramirez-Rivera A; Ferranti P; Holzer R; García JM; Turcotte C; Rapatz G; Pfister P; Overend T; Kottakis J
    Int J Clin Pract; 2001 Apr; 55(3):164-70. PubMed ID: 11351769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.